FSSNX
Price
$33.03
Change
+$2.04 (+6.58%)
Updated
Feb 3 closing price
Net Assets
29.73B
GQSCX
Price
$16.49
Change
+$1.77 (+12.02%)
Updated
Feb 3 closing price
Net Assets
2.64M
Interact to see
Advertisement

FSSNX vs GQSCX

Header iconFSSNX vs GQSCX Comparison
Open Charts FSSNX vs GQSCXBanner chart's image
Fidelity Small Cap Index
Price$33.03
Change+$2.04 (+6.58%)
VolumeN/A
Net Assets29.73B
Glenmede Disciplined US Small Cap Eq Ptf
Price$16.49
Change+$1.77 (+12.02%)
VolumeN/A
Net Assets2.64M
FSSNX vs GQSCX Comparison Chart in %
View a ticker or compare two or three
VS
FSSNX vs. GQSCX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSSNX is a Hold and GQSCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSSNX has more cash in the bank: 29.7B vs. GQSCX (2.64M). FSSNX pays higher dividends than GQSCX: FSSNX (1.03) vs GQSCX (0.23). FSSNX was incepted earlier than GQSCX: FSSNX (14 years) vs GQSCX (8 years). GQSCX (3.65) is less costly to investors than FSSNX (0.03). GQSCX is a more actively managed with annual turnover of: 92.00 vs. FSSNX (14.00). FSSNX (0) and GQSCX (0) have matching initial minimum investment requirements. FSSNX (18.62) and GQSCX (17.85) have marching annual gain over last year. GQSCX return over 5 years is better than : 30.52 vs. FSSNX (25.49).
FSSNXGQSCXFSSNX / GQSCX
Total Expense Ratio0.030.853%
Annual Report Gross Expense Ratio0.033.651%
Fund Existence14 years8 years-
Gain YTD6.4347.00892%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets29.7B2.64M1,126,280%
Annual Yield % from dividends1.030.23447%
Returns for 1 year18.6217.85104%
Returns for 3 years39.3225.00157%
Returns for 5 years25.4930.5284%
Returns for 10 years169.89N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LYEL25.771.00
+4.04%
Lyell Immunopharma Inc
RXO15.940.45
+2.91%
RXO
CPHI0.910.01
+1.11%
China Pharma Holdings Inc
PYXS1.49-0.04
-2.61%
Pyxis Oncology
J132.91-3.97
-2.90%
Jacobs Solutions